Reblozyl 75 MG vials
Ended Awarded
- Contract number
- SPE2DB25FXL83
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $78,912
Award facts
- Contract value 100% obligated
- $78,911.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $78,911.60 to AmerisourceBergen Drug Corp for the supply of Reblozyl 75 mg vials. This competitively awarded, firm fixed-price delivery order was issued on September 22, 2025, with an ultimate completion date of October 14, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors, serves as a critical supplier to federal medical procurement through the DLA's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. Reblozyl, a specialty pharmaceutical used in the treatment of blood disorders, represents the type of specialized medication that AmerisourceBergen supplies through its prime vendor relationship with DLA, supporting healthcare delivery across Department of Defense and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FXL83?
SPE2DB25FXL83 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FXL83 worth?
The government has obligated $78,912 on SPE2DB25FXL83.
Is contract SPE2DB25FXL83 an order under another contract?
Yes. SPE2DB25FXL83 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXL83 competed?
The extent of competition for SPE2DB25FXL83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award